Trial Profile
Efficacy of canakinumab in paediatric patients with cryopyrin-associated periodic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2015
Price :
$35
*
At a glance
- Drugs Canakinumab (Primary)
- Indications Cryopyrin-associated periodic syndromes
- Focus Therapeutic Use
- 27 May 2015 New trial record